|
"shao yu yun"的相关文件
显示项目 1-10 / 94 (共10页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2022-05-12T07:37:59Z |
Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma
|
Shao, Yu-Yun; Chen, Pai-Sheng; LIANG-IN LIN; Lee, Bin-Shyun; Ling, Andrew; Cheng, Ann-Lii; CHIUN HSU; Ou, Da-Liang |
| 臺大學術典藏 |
2022-05-12T02:20:13Z |
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
|
Chen, Ching-Tso; Liu, Tsung-Hao; Shao, Yu-Yun; KAO-LANG LIU; Liang, Po-Chin; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2022-04-14T07:44:52Z |
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma
|
Shao, Yu-Yun; Kuo, Hung-Yang; Jeng, Yung-Ming; YAO-MING WU; Wang, Hsiu-Po; CHIUN HSU; CHIH-HUNG HSU; Hsu, Hey-Chi; Cheng, Ann-Lii; Lin, Zhong-Zhe |
| 臺大學術典藏 |
2022-02-16T03:00:55Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao, Yu-Yun; Wang, Shen-Yung; Lin, Shi-Ming; Chen K.-Y.; Tseng J.-H.; Ho M.-C.; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; JA-DER LIANG |
| 臺大學術典藏 |
2022-01-14T03:38:07Z |
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy
|
Lin, Zhong-Zhe; Chen, Bang-Bin; Hung, Yi-Ping; HUANG, PO-HSIANG; Shen, Ying-Chun; Shao, Yu-Yun; Hsu, Chih-Hung; Cheng, Ann-Lii; Lee, Rheun-Chuan; Chao, Yee; Chiun Hsu |
| 臺大學術典藏 |
2021-12-16T03:39:19Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T03:25:51Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
Chen, Bang-Bin; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2021-12-16T02:10:26Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
BANG-BIN CHEN; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-16T02:03:28Z |
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II Trials
|
BANG-BIN CHEN; Lin, Zhong-Zhe; Shao, Yu-Yun; CHIUN HSU; Hsu, Chih-Hung; Cheng, Ann-Lii; Liang, Po-Chin; Shih, Tiffany Ting-Fang |
| 臺大學術典藏 |
2021-12-15T07:39:40Z |
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma
|
Chen, Bang-Bin; Shao, Yu-Yun; Lin, Zhong-Zhe; Hsu, Chih-Hung; Cheng, Ann-Lii; CHIUN HSU; PO-CHIN LIANG; Shih, Tiffany Ting-Fang |
显示项目 1-10 / 94 (共10页)
1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目
|
